MeiraGTx Holdings (MGTX) Asset Writedowns and Impairment (2023 - 2024)

MeiraGTx Holdings (MGTX) reported Asset Writedowns and Impairment of -$409000.0 for Q4 2024, down 438.16% on a YoY basis from $120949.4 in Q1 2024, and down 2456.25% quarter-over-quarter from -$16000.0 in Q3 2024.

MeiraGTx Holdings (MGTX) Asset Writedowns and Impairment (2023 - 2024) Analysis & Trends

MeiraGTx Holdings has reported Asset Writedowns and Impairment for 2 years, with the latest figure at -$409000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 MeiraGTx Holdings 910.47 Mn 844.54 Mn 74.89 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 -409,000.00
Dec 31, 2024 -409,000.00
Sep 30, 2024 -16,000.00
Sep 30, 2024 -16,000.00
Dec 31, 2023 -76,000.00
Dec 31, 2023 -76,000.00